Page last updated: 2024-10-20

pyrazinamide and Interstitial Nephritis

pyrazinamide has been researched along with Interstitial Nephritis in 1 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Research Excerpts

ExcerptRelevanceReference
"Pyrazinamide therapy has been associated with dose-dependent hepatotoxicity, hyperuricaemia, arthralgia and arthritis."5.28Tubulointerstitial nephritis associated with pyrazinamide. ( Kauffmann, RH; Sanwikarja, S; Serlie, J; te Velde, J, 1989)
"Pyrazinamide therapy has been associated with dose-dependent hepatotoxicity, hyperuricaemia, arthralgia and arthritis."1.28Tubulointerstitial nephritis associated with pyrazinamide. ( Kauffmann, RH; Sanwikarja, S; Serlie, J; te Velde, J, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sanwikarja, S1
Kauffmann, RH1
te Velde, J1
Serlie, J1

Other Studies

1 other study available for pyrazinamide and Interstitial Nephritis

ArticleYear
Tubulointerstitial nephritis associated with pyrazinamide.
    The Netherlands journal of medicine, 1989, Volume: 34, Issue:1-2

    Topics: Acute Kidney Injury; Adult; Humans; Male; Nephritis, Interstitial; Pyrazinamide; Tuberculosis, Pulmo

1989